IGM Biosciences (IGMS) Debt/EBITDA US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
Debt/EBITDA | 5.44 | 4.55 | 1.28 | 1.74 | 1.17 | 0.76 | ||
Changes by years, y/y, % | -3 999% | -16% | -72% | +36% | -33% |
IGM Biosciences. Debt/EBITDA
IGM Biosciences. Debt/EBITDA, changes, %
IGM Biosciences (IGMS) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 1.39 | 1.16 | 1.03 | 0.95 | 0.76 | 0.76 | ||
Changes by years, y/y, % | -32% | -32% | -27% | -33% | -45% | |||
Changes by quarters, q/q, % | -2% | -16% | -12% | -8% | -20% |